Valsartan can reduce the systolic pressure of Ang II treated ApoE-/- mice, promote the differentiation of CD4+T cells into Th2 cells and Tregs, improve the immune balance, and stabilize the atherosclerosis plaque (115). This evidence concerns the gene CD4 and atherosclerosis.